why choose us

First received: September 15, 2023

Clinical Trial: Delivering Transcutaneous Auricular Neurostimulation to Reduce Heavy Menstrual Bleeding in Patients With and Without Von Willebrand Disease

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Von Willebrand Disease, Type 1

Study Type: INTERVENTIONAL


Official Title: Delivering Transcutaneous Auricular Neurostimulation to Reduce Heavy Menstrual Bleeding in Patients With and Without Von Willebrand Disease

Brief Summary: The objectives of this study are to determine if transcutaneous auricular neurostimulation (tAN) can modulate hemostasis, improve perceived quality of life, and improve pain during the menstrual cycle of von Willebrand Disease (VWD) patients.

Read more